CanniMed Therapeutics, Inc. operates as a biopharmaceutical company. It specializes in the production of pharmaceutical-grade cannabis. The firm offers plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. The company was founded in 1988 and is headquartered in Saskatoon, Canada.